Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review
Journal
Oral Oncology
Journal Volume
53
Pages
10-16
Date Issued
2016
Author(s)
Ahn M.-J.
D'Cruz A.
Vermorken J.B.
Chitapanarux I.
Dang H.Q.T.
Guminski A.
Kannarunimit D.
Lin T.-Y.
Ng W.T.
Park K.-U.
Chan A.T.C.
Abstract
Toxicities resulting from platinum based chemotherapy in head and neck cancer is a cause for much concern. There is a lack of clinical criteria for defining these patient populations, which has posed serious problems associated with increased morbidity and consequently an adverse effect on patients' quality of life. In addition, there is a lack of consensus on clinical criteria for defining such patient populations, who may be unsuitable for concurrent chemoradiotherapy. A group of experts in the field of head and neck cancer from the Asia Pacific Region convened in August 2014 in Korea to discuss the development of a set of clinical criteria in order to fill the knowledge gap and provide a reference tool for head and neck oncologists. This paper reports the final output from this meeting and the accompanying literature review, with the aim of aiding clinical decision making with the help of some clinical criteria to identify platinum unsuitable patient populations in head and neck cancer management. Some alternative treatment options are also discussed in this paper. ? 2015 The Authors. Published by Elsevier Ltd.
Subjects
Chemoradiotherapy; Cisplatin; Criteria; Expert opinion; Head and neck cancer; Patients; Toxicity; Unsuitability
SDGs
Other Subjects
cetuximab; cisplatin; platinum; antineoplastic agent; cisplatin; chemoradiotherapy; clinical decision making; clinical practice; comorbidity; consensus; glomerulus filtration rate; head and neck cancer; high risk population; human; induction chemotherapy; kidney function; morbidity; nutritional status; practice guideline; priority journal; quality of life; Review; South Korea; weight reduction; adverse effects; Asia; Carcinoma, Squamous Cell; chemoradiotherapy; Head and Neck Neoplasms; procedures; treatment outcome; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asia; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Head and Neck Neoplasms; Humans; Quality of Life; Treatment Outcome
Publisher
Elsevier Ltd
Type
review